全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Cross-Reactivity against Naja sumatrana (Black Spitting Cobra) Envenoming from the Haffkine Antivenom in a Mouse Model

DOI: 10.1155/2013/247645

Full-Text   Cite this paper   Add to My Lib

Abstract:

Naja sumatrana is the dominant cobra species in Malaysia, Singapore, Borneo, and Sumatra, and it does not have specific antivenom. The Haffkine antivenom has been advocated instead. This study aims to determine the efficacy of this antivenom against Naja sumatrana envenoming using a mouse model. Methods. Male Swiss albino mice were used. Intravenous LD50 was first determined separately for Naja naja and Naja sumatrana venom. ED50 was determined by preincubating antivenom with each venom at 2.5 LD50 before administering the mixture into the tail vein. Validation was carried out using a challenge test. Each mouse received 111?μg of Naja sumatrana venom intramuscularly followed by intraperitoneal administration of dilute Haffkine antivenom. Survival was recorded 24 hours after envenoming. Results. The LD50 of Naja naja venom was 78.13?μg, standard error (SE) 13.3?μg. The ED50 of the Haffkine antivenom against Naja naja venom was 45.9?mg, SE 7.5?mg. The LD50 and ED50 of Naja sumatrana venom were 55.5?μg, SE 12.0?μg; and 73.9?mg, SE 12.0?mg, respectively. The intra-peritoneal ED50 against 111?μg intramuscular Naja sumatrana venom was 136.95?mg, SE 36.74?mg. Conclusion. The Haffkine polyvalent antivenom exhibited cross-neutralisation against Naja sumatrana venom when used at a higher dose. 1. Introduction 1.1. Background and Importance Naja sumatrana, commonly known as the black spitting cobra or Equatorial spitting cobra, is the dominant cobra species in Peninsular Malaysia, Singapore, Borneo, and Sumatra [1]. It was estimated that the highest burden of snake bites exists in South Asia, Southeast Asia, and sub-Saharan Africa [2]. Cobra bites are common in Peninsular Malaysia and require significant medical intervention [3, 4]. However, snake bites are considered uncommon in largely urban Singapore [5, 6]. Unfortunately specific antivenom therapy against the Naja sumatrana does not exist. The Haffkine antivenom was arbitrarily advocated as an antivenom. It is an equine polyvalent antivenom raised against the Indian binocellate cobra (Naja naja), common krait (Bungarus caeruleus), Russell’s viper (Vipera russelli), and saw-scaled viper (Echis carinatus) [7]. However, these species of snakes are not normally found in Southeast Asia. The antivenom composition of the Haffkine was chosen for the treatment of black spitting cobra snake bites due to the empirical belief that cobras are originated from the Naja naja. These species are, however, considered to be separate now. It is unknown if the Haffkine product has any effective paraspecific activity against the

References

[1]  W. Wüster, “Taxonomic changes and toxinology: systematic revisions of the asiatic cobras (Naja naja species complex),” Toxicon, vol. 34, no. 4, pp. 399–406, 1996.
[2]  A. Kasturiratne, A. R. Wickremasinghe, N. de Silva et al., “The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths,” PLoS Medicine, vol. 5, no. 11, pp. 1591–1604, 2008.
[3]  I. Jamaiah, M. Rohela, R. Roshalina, and R. C. Undan, “Prevalence of snake bites in Kangar District Hospital, Perlis, West Malaysia: a retrospective study (January 1999-December 2000),” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 35, no. 4, pp. 962–965, 2004.
[4]  I. Jamaiah, M. Rohela, T. K. Ng et al., “Retrospective prevalence of snakebites from Hospital Kuala Lumpur (HKL) (1999–2003),” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 37, no. 1, pp. 200–205, 2006.
[5]  R. Ponampalam, H. H. Tan, K. C. Ng, W. Y. Lee, and S. C. Tan, “Demographics of toxic exposures presenting to three public hospital emergency departments in Singapore 2001–2003,” International Journal of Emergency Medicine, vol. 2, no. 1, pp. 25–31, 2009.
[6]  H. H. Tan, “Epidemiology of snakebites from a general hospital in Singapore: a 5-year retrospective review (2004–2008),” Annals of the Academy of Medicine Singapore, vol. 39, no. 8, pp. 640–647, 2010.
[7]  R. C. Kankonkar, S. S. Rao, N. E. Vad, and M. V. Sant, “Efficacy of Haffkine Institute polyvalent antivenin against Indian snake venoms,” The Indian Journal of Medical Research, vol. 60, no. 4, pp. 512–516, 1972.
[8]  R. D. G. Theakston and H. A. Reid, “Development of simple standard assay procedures for the characterization of snake venoms,” Bulletin of the World Health Organization, vol. 61, no. 6, pp. 949–956, 1983.
[9]  L. J. Reed and H. Muench, “A simple method of estimating fifty per cent endpoints,” American Journal of Epidemiology, vol. 27, no. 3, pp. 493–497, 1938.
[10]  M. Pizzi, “Sampling variation of the fifty percent end-point, determined by the Reed-Muench (Behrens) method,” Human Biology, vol. 22, no. 3, pp. 151–190, 1950.
[11]  M. K. K. Yap, N. H. Tan, and S. Y. Fung, “Biochemical and toxinological characterization of Naja sumatrana (Equatorial spitting cobra) venom,” Journal of Venomous Animals and Toxins Including Tropical Diseases, vol. 17, no. 4, pp. 451–459, 2011.
[12]  N.-H. Tan and C.-S. Tan, “A comparative study of cobra (Naja) venom enzymes,” Comparative Biochemistry and Physiology Part B, vol. 90, no. 4, pp. 745–750, 1988.
[13]  R. Shashidharamurthy, D. K. Jagadeesha, K. S. Girish, and K. Kemparaju, “Variations in biochemical and pharmacological properties of Indian cobra (Naja naja naja) venom due to geographical distribution,” Molecular and Cellular Biochemistry, vol. 229, no. 1-2, pp. 93–101, 2002.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133